- When fully operational, new facility will house more than 500 highly skilled employees and bring more than 220 new jobs to Massachusetts
- Long-term investment places new US business headquarters at the heart of the most dynamic and growing life sciences, healthcare and biotech cluster in the US
- Furthers GE Healthcare Life Sciences' leadership in molecular and precision medicine, clinical diagnostics, manufacturing and R&D
MARLBOROUGH, Mass., Aug.
business unit
tags
ST. LOUIS -- Today at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, GE Healthcare introduced its Discovery* IQ^ PET/CT system, enabling both outstanding image quality and intelligent quantitation, helping physicians deliver the best possible patient outcomes.
business unit
tags
Princeton, NJ -- May 30, 2014 -- Effective from June 1st 2014 and following approval by the US Food and Drug Administration (FDA), GE Healthcare today announced the intent to supply generators for the production of sodium pertechnetate; technetium (Tc99m) injection to its radiopharmacies in the US.
business unit
tags
Philadelphia, PA, April 29, 2014 -- Data from a pooled analysis of four clinical trials, presented today at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, showed that using DaTscan™ (Ioflupane I 123 Injection) with single-photon emission computed tomography (SPECT) brain imaging was associated with a high level of diagnostic effectiveness.[i]